Pyruvate therapy for Leigh syndrome due to cytochrome c oxidase deficiency
Authors:
- Yutaka NishigakiYNYutaka Nishigaki
- Noriyuki FukuNoriyuki Fuku
- Hiroko HosoyaHHHiroko Hosoya
- Kei MurayamaKMKei Murayama
- Akira OhtakeAOAkira Ohtake
- Yu-Ichi GotoYGYu-Ichi Goto
- Hiroyuki WakamotoHWHiroyuki Wakamoto
- Yasutoshi KogaYKYasutoshi Koga
- Masashi TanakaMTMasashi Tanaka
- 1 March 2010
- journal article
- case report
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - General Subjects
- Vol. 1800 (3) , 313-315
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Leigh and Leigh-Like Syndrome in Children and AdultsPediatric Neurology, 2008
- Therapeutic potential of pyruvate therapy for mitochondrial diseasesMitochondrion, 2007
- Leigh Syndrome with Nephropathy and CoQ10 Deficiency Due to decaprenyl diphosphate synthase subunit 2 (PDSS2) MutationsThe American Journal of Human Genetics, 2006
- A Mutation in Para-Hydroxybenzoate-Polyprenyl Transferase (COQ2) Causes Primary Coenzyme Q10 DeficiencyThe American Journal of Human Genetics, 2006
- Diagnosis and molecular analysis of three male patients with thiamine-responsive pyruvate dehydrogenase complex deficiencyJournal of the Neurological Sciences, 2002
- Haemodynamic effects of intracoronary pyruvate in patients with congestive heart failure: an open studyThe Lancet, 1999
- Deficiency of respiratory chain complex I is a common cause of leigh diseaseAnnals of Neurology, 1996
- Leigh syndrome: Clinical features and biochemical and DNA abnormalitiesAnnals of Neurology, 1996
- Benign infantile mitochondrial myopathy due to reversible cytochrome c oxidase deficiencyAnnals of Neurology, 1983
- SUBACUTE NECROTIZING ENCEPHALOMYELOPATHY IN AN INFANTJournal of Neurology, Neurosurgery & Psychiatry, 1951